Sign In
Buy DVAX
$15.50
+0 (+0%)
At Close: May 08, 2026
Dynavax Technologies Corporation (NASDAQ: DVAX) Stock: Bulls Need To See This
12:00pm, Monday, 15'th Nov 2021 Stocks Register
Dynavax Technologies Corporation (NASDAQ:DVAX) price closed higher on Friday, November 12, jumping 3.29% above its previous close. >> 7 Top Picks for the Post-Pandemic Economy > 7 Top Picks for the Post-Pandemic Economy
Why Dynavax Stock Is Falling Today
12:16pm, Friday, 05'th Nov 2021
Shares of the vaccine maker are down sharply despite a positive earnings report.
Dynavax Technologies Corporation (DVAX) CEO Ryan Spencer on Q3 2021 Results - Earnings Call Transcript
10:21pm, Thursday, 04'th Nov 2021
Dynavax Technologies Corporation (DVAX) CEO Ryan Spencer on Q3 2021 Results - Earnings Call Transcript
Dynavax (DVAX) to Report Q3 Earnings: What's in the Cards?
03:24pm, Wednesday, 27'th Oct 2021
Dynavax's (DVAX) topline comprising sales of hepatitis B vaccine Heplisav-B, vaccine adjuvant CpG 1018 and other revenues is expected to retain the growth momentum in Q3 results.
The Momentum Investor: Spotlight On Dynavax Technologies
07:57pm, Monday, 25'th Oct 2021
The company has had successful drug trials. Earnings are rising.
Why Shares of Dynavax Technologies, Ocugen, and Valneva Are on the Move Today
01:49pm, Monday, 18'th Oct 2021
These COVID-19 vaccine developers are all moving in response to strong late-stage results for Valneva's VLA2001.
EMERYVILLE, Calif., Oct. 18, 2021 /PRNewswire/ -- Dynavax Technologies Corporation (Nasdaq: DVAX), a biopharmaceutical company focused on developing and commercializing vaccines, today announced that
Dynavax And TLR Biology: Long-Delayed But Outstanding Success
01:54pm, Saturday, 16'th Oct 2021
Dynavax developed CpG 1018 many years ago. The coronavirus pandemic gave CpG 1018 a vast market to tap.
EMERYVILLE, Calif., Oct. 4, 2021 /PRNewswire/ -- Dynavax Technologies Corporation (Nasdaq: DVAX), a biopharmaceutical company focused on developing and commercializing vaccines, and the U.S. Departmen
Dynavax to Present at Upcoming Investment Conferences
04:20pm, Monday, 27'th Sep 2021
EMERYVILLE, Calif., Sept. 27, 2021 /PRNewswire/ -- Dynavax Technologies Corporation (Nasdaq: DVAX), a biopharmaceutical company focused on developing and commercializing vaccines, today announced that
How Will Valneva's COVID Vaccine Setback Impact Dynavax?
05:55am, Saturday, 25'th Sep 2021
It's definitely not a showstopper for the biotech or its CpG 1018 adjuvant.
Dynavax (DVAX) Gains on Clover's COVID-19 Vaccine Study Data
12:14pm, Thursday, 23'rd Sep 2021
Dynavax (DVAX) stock gains as partner Clover announces strong efficacy of its COVID-19 vaccine candidate against the Delta variant in pivotal study data readout.
DVAX Stock: Why It Significantly Increased Today
08:23pm, Wednesday, 22'nd Sep 2021
The stock price of Dynavax Technologies Corporation (NASDAQ: DVAX) increased by over 25% today. This is why it happened.
Surging Dynavax Stock Could Soar Even Higher
02:00pm, Wednesday, 22'nd Sep 2021
Biopharmaceutical concern Dynavax Technologies Corporation (NASDAQ:DVAX) is up 33.9% to trade at $19.90 this afternoon.
DVAX Stock: What Is the Covid-19 News Lifting Dynavax Today?
01:15pm, Wednesday, 22'nd Sep 2021
Today, some impressive vaccine-related news has sent Dynavax and shares of DVAX stock significantly higher as investors pile in. The post DVAX Stock: What Is the Covid-19 News Lifting Dynavax Today?
